DUBLIN–(BUSINESS WIRE)–The “Global
Dry Eye Clinical Trial Pipeline Highlights – 2019” report has
been added to ResearchAndMarkets.com’s offering.
Dry Eye Pipeline Highlights – 2019, provides most up-to-date information
on key pipeline products in the global Dry Eye market. It covers
emerging therapies for Dry Eye in active clinical development stages
including early and late stage clinical trials. The pipeline data
presented in this report helps executives for tracking competition,
identifying partners, evaluating opportunities, formulating business
development strategies, and executing in-licensing and out-licensing
deals.
Clinical Trial Stages:
The report provides Dry Eye pipeline products by clinical trial stages
including both early and late stage development – phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.
Drug Mechanism Classes:
The report provides Dry Eye pipeline products by their dominant
mechanism of action/drug class. This helps executives categorize
products based on their drug class and also assess the strengths and
weaknesses of compounds.
Company:
The report provides Dry Eye pipeline products by the company.
Short-term Launch Highlights:
Find out which Dry Eye pipeline products will be launched in the US and
Ex-US till 2024.
Summary:
- Dry Eye phase 3 clinical trial pipeline products
- Dry Eye phase 2 clinical trial pipeline products
- Dry Eye phase 1 clinical trial pipeline products
- Dry Eye preclinical research pipeline products
- Dry Eye discovery stage pipeline products
- Dry Eye pipeline products short-term launch highlights
Key Topics Covered:
1. Dry Eye Pipeline by Stages
2. Dry Eye Phase 3 Clinical Trial Insights
3. Dry Eye Phase 2 Clinical Trial Insights
4. Dry Eye Phase 1 Clinical Trial Insights
5. Dry Eye Preclinical Research Insights
6. Dry Eye Discovery Stage Insights
7. Appendix
8. Research Methodology
For more information about this report visit https://www.researchandmarkets.com/r/dhx1jl
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Optical
Disorders Drugs